| VIFNVifor Pharma | CHF116.95 | 3.4% | -28.7% | CHF7.6b | CHF136.00 | P/E46.7x | 11.7% | 1.7% |
| ROGRoche Holding | CHF298.00 | 0.02% | -5.4% | CHF260.9b | CHF358.74 | P/E17.8x | 7.4% | 3.1% |
| IDIAIdorsia | CHF24.98 | 0.4% | -5.7% | CHF4.2b | CHF30.75 | P/E-8x | 16.6% | n/a |
| SKINCassiopea | CHF46.60 | 4.5% | 26.3% | CHF458.0m | CHF74.90 | P/E-39.7x | 61.5% | n/a |
| SANNSanthera Pharmaceuticals Holding | CHF3.25 | 0.6% | -59.6% | CHF69.2m | CHF5.35 | P/E-1.5x | 55.0% | n/a |
| WBIOWockhardt Bio | CHF2.74 | 0% | n/a | CHF142.3m | n/a | P/E6.3x | n/a | 0% |
| NWRNNewron Pharmaceuticals | CHF2.84 | 0% | -47.9% | CHF50.4m | CHF7.06 | P/E-2.7x | 52.3% | n/a |
| KURNKuros Biosciences | CHF2.20 | -0.5% | -9.1% | CHF72.1m | n/a | P/E-3.6x | n/a | n/a |
| POLNPolyphor | CHF7.59 | -1.3% | 21.4% | CHF86.0m | CHF7.95 | P/E-1.3x | 60.7% | n/a |
| ADXNAddex Therapeutics | CHF1.67 | -2.3% | 9.9% | CHF56.2m | CHF1.08 | P/E-3.1x | -19.5% | n/a |
| BSLNBasilea Pharmaceutica | CHF44.22 | -4.8% | 7.1% | CHF544.6m | CHF87.25 | P/E-30.9x | 58.1% | 0% |
| COPNCosmo Pharmaceuticals | CHF81.00 | -2.8% | 10.7% | CHF1.2b | CHF105.04 | P/E-157.6x | 84.4% | 0% |
| SFZNSiegfried Holding | CHF698.00 | -1.6% | 88.1% | CHF2.9b | CHF728.20 | P/E47.5x | 23.9% | 0.4% |
| RLFRelief Therapeutics Holding | CHF0.30 | -5.0% | 11,515.4% | CHF980.8m | n/a | P/E478.6x | n/a | n/a |
| MOLNMolecular Partners | CHF20.50 | -11.8% | 5.7% | CHF613.7m | CHF28.67 | P/E-8.2x | 65.4% | n/a |
| TECNTecan Group | CHF362.00 | -5.3% | 24.8% | CHF4.5b | CHF419.25 | P/E51.3x | 11.3% | 0.6% |
| BANBBachem Holding | CHF321.00 | -6.7% | 92.7% | CHF4.5b | CHF431.67 | P/E67.3x | 18.9% | 0.9% |
| NOVNNovartis | CHF76.89 | -1.7% | -3.0% | CHF176.5b | CHF99.86 | P/E23.3x | 8.6% | 3.9% |
| LONNLonza Group | CHF533.40 | -7.0% | 37.6% | CHF40.5b | CHF652.38 | P/E54.4x | 12.8% | 0.6% |